MOXI 1927 nm Thulium Laser
Low-downtime fractional thulium for dyspigmentation and photodamage
About This Treatment
MOXI is a nonablative fractional 1927 nm thulium laser targeting superficial water-containing tissue for dyspigmentation, photodamage, dullness and texture with low downtime.
Melasma-prone skin requires conservative settings and strict photoprotection.
Mechanism of Action
The 1927 nm wavelength is water-absorbed and creates superficial fractional thermal injury, driving epidermal turnover and shallow dermal remodeling.
Indications
Expected Results
Two to four sessions are assessed for dullness, actinic dyspigmentation and texture. Redness and sandpaper texture usually settle within days.
Clinical Evidence
Risks & Side Effects
Erythema, edema, roughness, PIH and melasma worsening may occur. Photoprotection and inflammation control are essential.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition